0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Beta-Nicotinamide Mononucleotide (NMN) Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-23V10935
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Beta Nicotinamide Mononucleotide NMN Market Research Report 2022
BUY CHAPTERS

Global Beta-Nicotinamide Mononucleotide (NMN) Market Research Report 2025

Code: QYRE-Auto-23V10935
Report
March 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Beta-Nicotinamide Mononucleotide (NMN) Market Size

The global market for Beta-Nicotinamide Mononucleotide (NMN) was valued at US$ 418 million in the year 2024 and is projected to reach a revised size of US$ 992 million by 2031, growing at a CAGR of 13.4% during the forecast period.

Beta-Nicotinamide Mononucleotide (NMN) Market

Beta-Nicotinamide Mononucleotide (NMN) Market

Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
NMN is a precursor of nicotinamide adenine dinucleotide (NAD+), which plays a vital role in cell metabolism and energy production. As we age, the level of NAD+ in the human body gradually decreases, resulting in weakened cell metabolism, which in turn triggers a series of aging-related diseases. Therefore, increasing the level of NAD+ in the body by supplementing NMN has become a new way to fight aging and maintain good health.
With the general improvement of global health awareness and continuous breakthroughs in scientific research and technology, the growth momentum of the NMN market will continue to increase. In the future, the NMN market will achieve a deeper cross-border integration with other health industries such as biotechnology, precision medicine, and nutritional supplements, giving rise to a series of innovative products and service models to meet consumers' more personalized and precise health needs.
At present, nicotinamide mononucleotide (NMN) is still in the development stage. There are not many manufacturers in the global market, and consumers have weak awareness of its use, especially in developing countries. The demand is lower than that in developed countries around the world, but the demand in developing countries is growing rapidly. Leading giants have proposed expansion plans and increased production bases.
Nicotinamide mononucleotide (NMN) core manufacturers include GeneHarbor, Mirailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production area, accounting for about 84% of the global market share, followed by North America and Japan. The downstream applications of nicotinamide mononucleotide include health products, cosmetics, etc. Globally, health products are the largest application market, and raw materials for health products account for 99% of the total sales of nicotinamide mononucleotide in 2023.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Beta-Nicotinamide Mononucleotide (NMN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beta-Nicotinamide Mononucleotide (NMN).
The Beta-Nicotinamide Mononucleotide (NMN) market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Beta-Nicotinamide Mononucleotide (NMN) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Beta-Nicotinamide Mononucleotide (NMN) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Beta-Nicotinamide Mononucleotide (NMN) Market Report

Report Metric Details
Report Name Beta-Nicotinamide Mononucleotide (NMN) Market
Accounted market size in year US$ 418 million
Forecasted market size in 2031 US$ 992 million
CAGR 13.4%
Base Year year
Forecasted years 2025 - 2031
by Type
  • Content ≥98%
  • Content <98%
by Application
  • Health Care Products
  • Cosmetics
  • Others
Production by Region
  • North America
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GeneHarbor, Herbalmax, Genex Formulas, Mirailab Bioscience, Maac10 Formulas, EffePharm, Bontac, CELFULL, Kingdomway, ABA Chemical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Beta-Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Beta-Nicotinamide Mononucleotide (NMN) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Beta-Nicotinamide Mononucleotide (NMN) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Beta-Nicotinamide Mononucleotide (NMN) Market growing?

Ans: The Beta-Nicotinamide Mononucleotide (NMN) Market witnessing a CAGR of 13.4% during the forecast period 2025-2031.

What is the Beta-Nicotinamide Mononucleotide (NMN) Market size in 2031?

Ans: The Beta-Nicotinamide Mononucleotide (NMN) Market size in 2031 will be US$ 992 million.

What is the Beta-Nicotinamide Mononucleotide (NMN) Market production share by region?

Ans: China is the largest production area, accounting for about 84% of the global market share, followed by North America and Japan.

Who are the main players in the Beta-Nicotinamide Mononucleotide (NMN) Market report?

Ans: The main players in the Beta-Nicotinamide Mononucleotide (NMN) Market are GeneHarbor, Herbalmax, Genex Formulas, Mirailab Bioscience, Maac10 Formulas, EffePharm, Bontac, CELFULL, Kingdomway, ABA Chemical

What are the Application segmentation covered in the Beta-Nicotinamide Mononucleotide (NMN) Market report?

Ans: The Applications covered in the Beta-Nicotinamide Mononucleotide (NMN) Market report are Health Care Products, Cosmetics, Others

What are the Type segmentation covered in the Beta-Nicotinamide Mononucleotide (NMN) Market report?

Ans: The Types covered in the Beta-Nicotinamide Mononucleotide (NMN) Market report are Content ≥98%, Content <98%

Recommended Reports

Nicotinamide & Nucleotides

Neuro & Disease Therapeutics

High Purity Chemicals

1 Beta-Nicotinamide Mononucleotide (NMN) Market Overview
1.1 Product Definition
1.2 Beta-Nicotinamide Mononucleotide (NMN) by Type
1.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Content ≥98%
1.2.3 Content <98%
1.3 Beta-Nicotinamide Mononucleotide (NMN) by Application
1.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Health Care Products
1.3.3 Cosmetics
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts (2020-2031)
1.4.4 Global Beta-Nicotinamide Mononucleotide (NMN) Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Manufacturers (2020-2025)
2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Beta-Nicotinamide Mononucleotide (NMN), Industry Ranking, 2023 VS 2024
2.4 Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Product Offered and Application
2.8 Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Date of Enter into This Industry
2.9 Beta-Nicotinamide Mononucleotide (NMN) Market Competitive Situation and Trends
2.9.1 Beta-Nicotinamide Mononucleotide (NMN) Market Concentration Rate
2.9.2 Global 5 and 10 Largest Beta-Nicotinamide Mononucleotide (NMN) Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Beta-Nicotinamide Mononucleotide (NMN) Production by Region
3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Region (2020-2031)
3.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Beta-Nicotinamide Mononucleotide (NMN) by Region (2026-2031)
3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Beta-Nicotinamide Mononucleotide (NMN) Production Volume by Region (2020-2031)
3.4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Beta-Nicotinamide Mononucleotide (NMN) by Region (2026-2031)
3.5 Global Beta-Nicotinamide Mononucleotide (NMN) Market Price Analysis by Region (2020-2025)
3.6 Global Beta-Nicotinamide Mononucleotide (NMN) Production and Value, Year-over-Year Growth
3.6.1 North America Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2020-2031)
3.6.2 China Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2020-2031)
3.6.3 Japan Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2020-2031)
4 Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region
4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (2020-2031)
4.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (2020-2025)
4.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Type (2020-2031)
5.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Type (2020-2025)
5.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Type (2026-2031)
5.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2020-2031)
5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Type (2020-2031)
5.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Type (2020-2025)
5.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Type (2026-2031)
5.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2020-2031)
5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Type (2020-2031)
6 Segment by Application
6.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Application (2020-2031)
6.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Application (2020-2025)
6.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Application (2026-2031)
6.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2020-2031)
6.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Application (2020-2031)
6.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Application (2020-2025)
6.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Application (2026-2031)
6.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2020-2031)
6.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Application (2020-2031)
7 Key Companies Profiled
7.1 GeneHarbor
7.1.1 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Company Information
7.1.2 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)
7.1.4 GeneHarbor Main Business and Markets Served
7.1.5 GeneHarbor Recent Developments/Updates
7.2 Herbalmax
7.2.1 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Company Information
7.2.2 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Herbalmax Main Business and Markets Served
7.2.5 Herbalmax Recent Developments/Updates
7.3 Genex Formulas
7.3.1 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Company Information
7.3.2 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Genex Formulas Main Business and Markets Served
7.3.5 Genex Formulas Recent Developments/Updates
7.4 Mirailab Bioscience
7.4.1 Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Company Information
7.4.2 Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.4.3 Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Mirailab Bioscience Main Business and Markets Served
7.4.5 Mirailab Bioscience Recent Developments/Updates
7.5 Maac10 Formulas
7.5.1 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Company Information
7.5.2 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Maac10 Formulas Main Business and Markets Served
7.5.5 Maac10 Formulas Recent Developments/Updates
7.6 EffePharm
7.6.1 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Company Information
7.6.2 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)
7.6.4 EffePharm Main Business and Markets Served
7.6.5 EffePharm Recent Developments/Updates
7.7 Bontac
7.7.1 Bontac Beta-Nicotinamide Mononucleotide (NMN) Company Information
7.7.2 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Bontac Main Business and Markets Served
7.7.5 Bontac Recent Developments/Updates
7.8 CELFULL
7.8.1 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Company Information
7.8.2 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)
7.8.4 CELFULL Main Business and Markets Served
7.8.5 CELFULL Recent Developments/Updates
7.9 Kingdomway
7.9.1 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Company Information
7.9.2 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Kingdomway Main Business and Markets Served
7.9.5 Kingdomway Recent Developments/Updates
7.10 ABA Chemical
7.10.1 ABA Chemical Beta-Nicotinamide Mononucleotide (NMN) Company Information
7.10.2 ABA Chemical Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.10.3 ABA Chemical Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)
7.10.4 ABA Chemical Main Business and Markets Served
7.10.5 ABA Chemical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Beta-Nicotinamide Mononucleotide (NMN) Industry Chain Analysis
8.2 Beta-Nicotinamide Mononucleotide (NMN) Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Beta-Nicotinamide Mononucleotide (NMN) Production Mode & Process Analysis
8.4 Beta-Nicotinamide Mononucleotide (NMN) Sales and Marketing
8.4.1 Beta-Nicotinamide Mononucleotide (NMN) Sales Channels
8.4.2 Beta-Nicotinamide Mononucleotide (NMN) Distributors
8.5 Beta-Nicotinamide Mononucleotide (NMN) Customer Analysis
9 Beta-Nicotinamide Mononucleotide (NMN) Market Dynamics
9.1 Beta-Nicotinamide Mononucleotide (NMN) Industry Trends
9.2 Beta-Nicotinamide Mononucleotide (NMN) Market Drivers
9.3 Beta-Nicotinamide Mononucleotide (NMN) Market Challenges
9.4 Beta-Nicotinamide Mononucleotide (NMN) Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Beta-Nicotinamide Mononucleotide (NMN) Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Beta-Nicotinamide Mononucleotide (NMN) Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Beta-Nicotinamide Mononucleotide (NMN) Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Beta-Nicotinamide Mononucleotide (NMN) Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Beta-Nicotinamide Mononucleotide (NMN), Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Beta-Nicotinamide Mononucleotide (NMN) as of 2024)
 Table 10. Global Market Beta-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (US$/Kg) & (2020-2025)
 Table 11. Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Product Offered and Application
 Table 13. Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Date of Enter into This Industry
 Table 14. Global Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region (2020-2025)
 Table 19. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Beta-Nicotinamide Mononucleotide (NMN) Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Beta-Nicotinamide Mononucleotide (NMN) Production (Tons) by Region (2020-2025)
 Table 23. Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2020-2025)
 Table 24. Global Beta-Nicotinamide Mononucleotide (NMN) Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Beta-Nicotinamide Mononucleotide (NMN) Market Average Price (US$/Kg) by Region (2020-2025)
 Table 27. Global Beta-Nicotinamide Mononucleotide (NMN) Market Average Price (US$/Kg) by Region (2026-2031)
 Table 28. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region (2020-2025)
 Table 31. Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Beta-Nicotinamide Mononucleotide (NMN) Production (Tons) by Type (2020-2025)
 Table 46. Global Beta-Nicotinamide Mononucleotide (NMN) Production (Tons) by Type (2026-2031)
 Table 47. Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2020-2025)
 Table 48. Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2026-2031)
 Table 49. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2020-2025)
 Table 52. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2026-2031)
 Table 53. Global Beta-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Type (2020-2025)
 Table 54. Global Beta-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Type (2026-2031)
 Table 55. Global Beta-Nicotinamide Mononucleotide (NMN) Production (Tons) by Application (2020-2025)
 Table 56. Global Beta-Nicotinamide Mononucleotide (NMN) Production (Tons) by Application (2026-2031)
 Table 57. Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2020-2025)
 Table 58. Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2026-2031)
 Table 59. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2020-2025)
 Table 62. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2026-2031)
 Table 63. Global Beta-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Application (2020-2025)
 Table 64. Global Beta-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Application (2026-2031)
 Table 65. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Company Information
 Table 66. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 67. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 68. GeneHarbor Main Business and Markets Served
 Table 69. GeneHarbor Recent Developments/Updates
 Table 70. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Company Information
 Table 71. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 72. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 73. Herbalmax Main Business and Markets Served
 Table 74. Herbalmax Recent Developments/Updates
 Table 75. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Company Information
 Table 76. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 77. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 78. Genex Formulas Main Business and Markets Served
 Table 79. Genex Formulas Recent Developments/Updates
 Table 80. Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Company Information
 Table 81. Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 82. Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 83. Mirailab Bioscience Main Business and Markets Served
 Table 84. Mirailab Bioscience Recent Developments/Updates
 Table 85. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Company Information
 Table 86. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 87. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. Maac10 Formulas Main Business and Markets Served
 Table 89. Maac10 Formulas Recent Developments/Updates
 Table 90. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Company Information
 Table 91. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 92. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. EffePharm Main Business and Markets Served
 Table 94. EffePharm Recent Developments/Updates
 Table 95. Bontac Beta-Nicotinamide Mononucleotide (NMN) Company Information
 Table 96. Bontac Beta-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 97. Bontac Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 98. Bontac Main Business and Markets Served
 Table 99. Bontac Recent Developments/Updates
 Table 100. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Company Information
 Table 101. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 102. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 103. CELFULL Main Business and Markets Served
 Table 104. CELFULL Recent Developments/Updates
 Table 105. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Company Information
 Table 106. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 107. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 108. Kingdomway Main Business and Markets Served
 Table 109. Kingdomway Recent Developments/Updates
 Table 110. ABA Chemical Beta-Nicotinamide Mononucleotide (NMN) Company Information
 Table 111. ABA Chemical Beta-Nicotinamide Mononucleotide (NMN) Specification and Application
 Table 112. ABA Chemical Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 113. ABA Chemical Main Business and Markets Served
 Table 114. ABA Chemical Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Beta-Nicotinamide Mononucleotide (NMN) Distributors List
 Table 118. Beta-Nicotinamide Mononucleotide (NMN) Customers List
 Table 119. Beta-Nicotinamide Mononucleotide (NMN) Market Trends
 Table 120. Beta-Nicotinamide Mononucleotide (NMN) Market Drivers
 Table 121. Beta-Nicotinamide Mononucleotide (NMN) Market Challenges
 Table 122. Beta-Nicotinamide Mononucleotide (NMN) Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Beta-Nicotinamide Mononucleotide (NMN)
 Figure 2. Global Beta-Nicotinamide Mononucleotide (NMN) Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Type: 2024 VS 2031
 Figure 4. Content ≥98% Product Picture
 Figure 5. Content <98% Product Picture
 Figure 6. Global Beta-Nicotinamide Mononucleotide (NMN) Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Application: 2024 VS 2031
 Figure 8. Health Care Products
 Figure 9. Cosmetics
 Figure 10. Others
 Figure 11. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) & (2020-2031)
 Figure 13. Global Beta-Nicotinamide Mononucleotide (NMN) Production Capacity (Tons) & (2020-2031)
 Figure 14. Global Beta-Nicotinamide Mononucleotide (NMN) Production (Tons) & (2020-2031)
 Figure 15. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price (US$/Kg) & (2020-2031)
 Figure 16. Beta-Nicotinamide Mononucleotide (NMN) Report Years Considered
 Figure 17. Beta-Nicotinamide Mononucleotide (NMN) Production Share by Manufacturers in 2024
 Figure 18. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Share by Manufacturers (2024)
 Figure 19. Beta-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. The Global 5 and 10 Largest Players: Market Share by Beta-Nicotinamide Mononucleotide (NMN) Revenue in 2024
 Figure 21. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 22. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 23. Global Beta-Nicotinamide Mononucleotide (NMN) Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 24. Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 25. North America Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. China Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. Japan Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 29. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 30. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 31. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2020-2031)
 Figure 32. U.S. Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 33. Canada Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 34. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 35. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2020-2031)
 Figure 36. Germany Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 37. France Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 38. U.K. Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. Italy Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 40. Russia Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 41. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region (2020-2031)
 Figure 43. China Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 44. Japan Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 45. South Korea Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. China Taiwan Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 47. Southeast Asia Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 48. India Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2020-2031)
 Figure 51. Mexico Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 52. Brazil Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 53. Turkey Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. GCC Countries Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 55. Global Production Market Share of Beta-Nicotinamide Mononucleotide (NMN) by Type (2020-2031)
 Figure 56. Global Production Value Market Share of Beta-Nicotinamide Mononucleotide (NMN) by Type (2020-2031)
 Figure 57. Global Beta-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Type (2020-2031)
 Figure 58. Global Production Market Share of Beta-Nicotinamide Mononucleotide (NMN) by Application (2020-2031)
 Figure 59. Global Production Value Market Share of Beta-Nicotinamide Mononucleotide (NMN) by Application (2020-2031)
 Figure 60. Global Beta-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Application (2020-2031)
 Figure 61. Beta-Nicotinamide Mononucleotide (NMN) Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona